UBS AM’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.35M | Buy |
213,846
+82,550
| +63% | +$1.68M | ﹤0.01% | 1781 |
|
|
2025
Q1 | $2.38M | Buy |
131,296
+14,979
| +13% | +$272K | ﹤0.01% | 1905 |
|
|
2024
Q4 | $2.94M | Buy |
116,317
+13,722
| +13% | +$347K | ﹤0.01% | 1861 |
|
|
2024
Q3 | $3.49M | Buy |
102,595
+6,269
| +7% | +$213K | ﹤0.01% | 1759 |
|
|
2024
Q2 | $3.57M | Buy |
96,326
+57,617
| +149% | +$2.13M | ﹤0.01% | 1681 |
|
|
2024
Q1 | $1.62M | Buy |
38,709
+3,841
| +11% | +$161K | ﹤0.01% | 1777 |
|
|
2023
Q4 | $1.38M | Hold |
34,868
| – | – | ﹤0.01% | 1864 |
|
|
2023
Q3 | $960K | Buy |
34,868
+3,120
| +10% | +$85.9K | ﹤0.01% | 1980 |
|
|
2023
Q2 | $1.14M | Hold |
31,748
| – | – | ﹤0.01% | 1937 |
|
|
2023
Q1 | $1.14M | Buy |
31,748
+1,506
| +5% | +$54.2K | ﹤0.01% | 1937 |
|
|
2022
Q4 | $1.35M | Hold |
30,242
| – | – | ﹤0.01% | 1710 |
|
|
2022
Q3 | $850K | Buy |
30,242
+803
| +3% | +$22.6K | ﹤0.01% | 2062 |
|
|
2022
Q2 | $794K | Sell |
29,439
-3,650
| -11% | -$98.4K | ﹤0.01% | 2084 |
|
|
2022
Q1 | $1.13M | Hold |
33,089
| – | – | ﹤0.01% | 2076 |
|
|
2021
Q4 | $1.28M | Sell |
33,089
-3,121
| -9% | -$121K | ﹤0.01% | 2074 |
|
|
2021
Q3 | $1.95M | Buy |
36,210
+2,198
| +6% | +$119K | ﹤0.01% | 1850 |
|
|
2021
Q2 | $1.14M | Sell |
34,012
-1,365
| -4% | -$45.6K | ﹤0.01% | 2140 |
|
|
2021
Q1 | $729K | Buy |
35,377
+1,390
| +4% | +$28.6K | ﹤0.01% | 2230 |
|
|
2020
Q4 | $595K | Buy |
+33,987
| New | +$595K | ﹤0.01% | 2235 |
|
|
2018
Q2 | – | Sell |
-2,560
| Closed | -$89.5K | – | 2788 |
|
|
2018
Q1 | $89.5K | Hold |
2,560
| – | – | ﹤0.01% | 2468 |
|
|
2017
Q4 | $109K | Hold |
2,560
| – | – | ﹤0.01% | 2394 |
|
|
2017
Q3 | $110K | Hold |
2,560
| – | – | ﹤0.01% | 2358 |
|
|
2017
Q2 | $94.8K | Sell |
2,560
-2,644
| -51% | -$98K | ﹤0.01% | 2347 |
|
|
2017
Q1 | $282K | Buy |
5,204
+2,644
| +103% | +$143K | ﹤0.01% | 2033 |
|
|
2016
Q4 | $136K | Sell |
2,560
-640
| -20% | -$34K | ﹤0.01% | 2203 |
|
|
2016
Q3 | $194K | Hold |
3,200
| – | – | ﹤0.01% | 2469 |
|
|
2016
Q2 | $211K | Sell |
3,200
-736
| -19% | -$48.5K | ﹤0.01% | 2416 |
|
|
2016
Q1 | $223K | Sell |
3,936
-65,785
| -94% | -$3.73M | ﹤0.01% | 2379 |
|
|
2015
Q4 | $16.4M | Sell |
69,721
-11,813
| -14% | -$2.78M | 0.02% | 731 |
|
|
2015
Q3 | $12.9M | Buy |
81,534
+3,664
| +5% | +$579K | 0.01% | 811 |
|
|
2015
Q2 | $29.5M | Buy |
77,870
+2,295
| +3% | +$868K | 0.03% | 588 |
|
|
2015
Q1 | $31.6M | Buy |
75,575
+13,100
| +21% | +$5.48M | 0.03% | 571 |
|
|
2014
Q4 | $17.1M | Buy |
62,475
+14,673
| +31% | +$4.02M | 0.02% | 736 |
|
|
2014
Q3 | $9.29M | Buy |
47,802
+1,076
| +2% | +$209K | 0.01% | 859 |
|
|
2014
Q2 | $11.4M | Sell |
46,726
-1,113
| -2% | -$272K | 0.01% | 810 |
|
|
2014
Q1 | $12.7M | Buy |
47,839
+28,937
| +153% | +$7.67M | 0.01% | 785 |
|
|
2013
Q4 | $6.86M | Buy |
18,902
+13,591
| +256% | +$4.94M | 0.01% | 929 |
|
|
2013
Q3 | $2.82M | Buy |
5,311
+2,548
| +92% | +$1.35M | ﹤0.01% | 1134 |
|
|
2013
Q2 | $647K | Buy |
+2,763
| New | +$647K | ﹤0.01% | 1605 |
|